Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001470831-25-000418
Filing Date
2025-12-16
Accepted
2025-12-16 18:24:17
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1765927454.html 4  
1 FORM 4 wk-form4_1765927454.xml 4 3376
  Complete submission text file 0001470831-25-000418.txt   4941
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3160 PORTER DRIVE SUITE 250 C/O BRIDGEBIO PHARMA, INC. PALO ALTO CA 94304
Business Address
Apuli Maricel (Reporting) CIK: 0002058197 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 251576779